These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6210785)

  • 1. A thrombotic tendency in patients with infective endocarditis.
    Fukuda Y; Kuroiwa Y; Tabuchi H; Ohshige T; Sanada J; Minami Y; Takaoka S; Kataoka H; Furukawa S; Miyahara K; Nakamura K; Hashimoto S
    Jpn Circ J; 1982 May; 46(5):460-7. PubMed ID: 6210785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of infective endocarditis on blood coagulation and platelet activation and comparison of patients with to those without embolic events.
    Ileri M; Alper A; Senen K; Durmaz T; Atak R; Hisar I; Yetkin E; Turhan H; Demirkan D
    Am J Cardiol; 2003 Mar; 91(6):689-92. PubMed ID: 12633799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on platelets and coagulofibrinolytic system in ischemic heart disease].
    Kuroiwa Y
    Igaku Kenkyu; 1988 Dec; 58(6):383-95. PubMed ID: 2978105
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypercoagulability in patients with mitral stenosis -- from the viewpoint of the behavior of plasma antithrombin III and alpha2-plasmin inhibitor.
    Fukuda Y; Kuroiwa Y; Okumiya K; Kuroiwa N; Ohshige T; Tabuchi H; Sanada J; Takaoka S; Minami Y; Kataoka H; Furukawa S; Miyahara K; Nakamura K; Hashimoto S
    Jpn Circ J; 1980 Nov; 44(11):867-74. PubMed ID: 7431647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased blood coagulation and platelet activation in patients with infective endocarditis and embolic events.
    Buyukasýk NS; Ileri M; Alper A; Senen K; Atak R; Hisar I; Yetkin E; Turhan H; Demirkan D
    Clin Cardiol; 2004 Mar; 27(3):154-8. PubMed ID: 15049384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The incidence of thromboembolism and the hemocoagulative background in patients with rheumatic heart disease.
    Fukuda Y; Nakamura K
    Jpn Circ J; 1984 Jan; 48(1):59-66. PubMed ID: 6198532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes, a hypercoagulable state? Hemostatic variables in newly diagnosed type 2 diabetic patients.
    Hughes A; McVerry BA; Wilkinson L; Goldstone AH; Lewis D; Bloom A
    Acta Haematol; 1983; 69(4):254-9. PubMed ID: 6219531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelets and antithrombin III in uraemia: the acute effect of haemodialysis.
    Knudsen F; Dyerberg J
    Scand J Clin Lab Invest; 1985 Jun; 45(4):341-7. PubMed ID: 3160101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of nisoldipine on cytosolic calcium, platelet aggregation, and coagulation/fibrinolysis in patients with coronary artery disease.
    Fujinishi A; Takahara K; Ohba C; Nakashima Y; Kuroiwa A
    Angiology; 1997 Jun; 48(6):515-21. PubMed ID: 9194537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The coagulation system is activated in idiopathic cardiomyopathy.
    Yamamoto K; Ikeda U; Furuhashi K; Irokawa M; Nakayama T; Shimada K
    J Am Coll Cardiol; 1995 Jun; 25(7):1634-40. PubMed ID: 7539015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemostasis, platelet function and serotonin in acute and chronic renal failure.
    Malyszko J; Malyszko JS; Pawlak D; Pawlak K; Buczko W; Mysliwiec M
    Thromb Res; 1996 Sep; 83(5):351-61. PubMed ID: 8873344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antithrombin III and alpha-2-antiplasmin activities compared with other hemostasis parameters in uncomplicated diabetes mellitus, type 2].
    Kotschy M; Drewniak W; Graczykowska-Koczorowska A; Listopadzki D
    Pol Tyg Lek; 1992 Jan 6-13; 47(1-2):17-8. PubMed ID: 1409034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulation-fibrinolysis system in poststroke patients receiving antiplatelet medication.
    Tohgi H; Takahashi H; Chiba K; Tamura K
    Stroke; 1993 Jun; 24(6):801-4. PubMed ID: 8506551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced alpha-2-antiplasmin levels in the nephrotic syndrome.
    Francis RB; Sandler RM; Levitan D; Feinstein EI; Massry SG; Feinstein DI
    Nephron; 1985; 39(4):325-9. PubMed ID: 3157072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circadian variation in platelet function in healthy volunteers.
    Jafri SM; VanRollins M; Ozawa T; Mammen EF; Goldberg AD; Goldstein S
    Am J Cardiol; 1992 Apr; 69(9):951-4. PubMed ID: 1532287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postangioplasty restenosis: platelet activation and the coagulation-fibrinolysis system as possible factors in the pathogenesis of restenosis.
    Ishiwata S; Tukada T; Nakanishi S; Nishiyama S; Seki A
    Am Heart J; 1997 Apr; 133(4):387-92. PubMed ID: 9124158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The haemocoagulation system and macroangiopathy in insulin dependent (type I) diabetes.
    Fuller JH
    Ann Clin Res; 1984; 16(3):137-41. PubMed ID: 6236737
    [No Abstract]   [Full Text] [Related]  

  • 18. A study of platelet functions, some hemostatic and fibrinolytic parameters in relation to serotonin in hemodialyzed patients under erythropoietin therapy.
    Malyszko J; Malyszko JS; Borawski J; Rydzewski A; Kalinowski M; Azzadin A; Mysliwiec M; Buczko W
    Thromb Res; 1995 Jan; 77(2):133-43. PubMed ID: 7740505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prethrombotic state due to hypercoagulability in patients with permanent transvenous pacemakers.
    Ito T; Tanouchi J; Kato J; Nishino M; Iwai K; Tanahashi H; Hori M; Yamada Y; Kamada T
    Angiology; 1997 Oct; 48(10):901-6. PubMed ID: 9342969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelets, coagulation and fibrinolysis in patients with diabetic retinopathy.
    Brooks AM; Hussein S; Chesterman CN; Martin JF; Alford FP; Penington DG
    Thromb Haemost; 1983 Apr; 49(2):123-7. PubMed ID: 6223403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.